78Approvals required for activities involving Schedule 8 substances—the Act, s 69(1)

78 Approvals required for activities involving Schedule 8 substances—the Act, s 69(1)

78 Approvals required for activities involving Schedule 8 substances—the Act, s 69(1)

(1) A medical practitioner or authorised nurse must not supply, administer or issue a prescription for a Schedule 8 substance without an approval in the following circumstances—

(a) the patient has a substance dependence on a prohibited scheduled substance or prohibited drug,

(b) the Schedule 8 substance is—

(i) dexamfetamine, lisdexamfetamine or methylphenidate, or

(ii) for medical practitioners only—N,?-dimethyl-3,4-(methylenedioxy)phenylethylamine (MDMA) or psilocybine,

(c) the Schedule 8 substance is morphine, oxycodone, fentanyl or hydromorphone and the amount is more than the morphine equivalent maximum dose,

(d) the substance (the relevant substance) is alprazolam, flunitrazepam, methadone or a Schedule 8 substance in an injectable or intranasal preparation, and the supply, administration or issue of the prescription would result in supply for a period in which, together with all other periods for which any relevant substance has been prescribed by the practitioner or has, to the practitioner’s knowledge, been prescribed by another person, one or more relevant substances are supplied for continuous therapeutic use by the patient for more than 3 months.

(2) In this section—

authorised nurse means—

(a) a nurse practitioner, or

(b) a registered nurse with an endorsement.